Search results for " bleeding."

showing 10 items of 139 documents

Stentgraft-Implantation for Treatment of Internal Carotid Artery Injury during Endonasal Sinus Surgery

2007

Background Damage of the internal carotid artery (ICA) is very rare but can be a dramatic complication of endonasal sinus surgery. In the literature only a few cases are reported, some of them with fatal results. Methods We present two cases with massive bleeding of the ICA caused by endonasal sinus surgery. Results In both cases bleeding could be stopped sufficiently by implanting a stentgraft. Conclusion The lumen of the artery could be preserved and no neurological deficits were observed.

AdultMalemedicine.medical_specialtySphenoid SinusCarotid arteriesLumen (anatomy)03 medical and health sciences0302 clinical medicinemedicine.arteryParanasal SinusesMassive bleedingHumansMedicineIntraoperative Complications030223 otorhinolaryngologyVascular Patencybusiness.industryEndoscopySinus surgerySurgeryEpistaxismedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisInternal carotid artery injuryFemaleStentsInternal carotid arteryCarotid Artery InjuriesbusinessComplicationAneurysm FalseMagnetic Resonance AngiographyArteryAmerican Journal of Rhinology
researchProduct

Predictors of Re‐bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic S…

2018

Abstract Background Transjugular intrahepatic portosystemic shunt (TIPS) has proven clinical efcacy as rescue therapy for cirrhotic patients with acute portal hypertensive bleeding who fail endoscopic treatment. Aims To investigate predictive factors of 6-week and 1-year mortality in patients undergoing salvage TIPS for refractory portal hypertensive bleeding. Methods A total of 144 consecutive patients were retrospectively evaluated. Three logistic regression multivariate models were estimated to individualize prognostic factors for 6-week and 12-month mortality. Log-rank test was used to evaluate survival according to Child–Pugh classes and Bureau’s criteria. Results Mean age 51±10 years,…

AdultMalemedicine.medical_specialtyVariceal bleedingPhysiologymedicine.medical_treatmentPortal venous pressureEsophageal and Gastric VaricesLogistic regressionlaw.inventionCohort Studies03 medical and health sciences0302 clinical medicineRefractoryPredictive Value of TestsRecurrencelawInternal medicinemedicineHumansProspective StudiesMortalityRetrospective StudiesSalvage Therapybusiness.industryGastroenterologyMiddle AgedHepatologyIntensive care unitSurgeryRe bleeding030220 oncology & carcinogenesisTIPSFemale030211 gastroenterology & hepatologyPortasystemic Shunt Transjugular IntrahepaticGastrointestinal HemorrhagebusinessTransjugular intrahepatic portosystemic shunt
researchProduct

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with…

2018

Summary Venous thromboembolism (VTE)‐BLEED, a decision tool for predicting major bleeding during chronic anticoagulation for VTE has not yet been validated in practice‐based conditions. We calculated the prognostic indices of VTE‐BLEED for major bleeding after day 30 and day 90, as well as for recurrent VTE and all‐cause mortality, in 4457 patients enrolled in the international, prospective XALIA study. The median at‐risk time was 190 days (interquartile range 106–360). The crude hazard ratio (HR) for major bleeding after day 30 was 2·6 [95% confidence interval (CI) 1·3–5·2] and the treatment‐adjusted HR was 2·3 (95% CI 1·1–4·5) for VTE‐BLEED high (versus low) risk patients: the correspondi…

AdultMalemedicine.medical_specialtyvenous thromboembolismHemorrhage030204 cardiovascular system & hematologyDisease-Free Survival03 medical and health sciencesYoung Adult0302 clinical medicineInterquartile rangePredictive Value of TestsInternal medicinemedicineanticoagulation therapy; bleeding; prediction; rivaroxaban; venous thromboembolism; HematologyHumans030212 general & internal medicinecardiovascular diseasesProspective StudiesAdverse effectrivaroxabanRivaroxabananticoagulation therapybusiness.industryIncidence (epidemiology)Platelets Haemostasis and ThrombosisHazard ratioHematologypredictionBleedMiddle Agedequipment and suppliesbleedingConfidence intervalddc:Survival RateCohortFemalebusinessmedicine.drugResearch Paper
researchProduct

Primary umbilical endometrioma: Analyzing the pathogenesis of endometriosis from an unusual localization

2015

Abstract Objective This report presents a rare case of symptomatic primary umbilical endometriosis and reviews the literature on the topic with the aim to clarify some questions on the origin of endometriosis. Case report A 33-year-old woman with cyclic umbilical bleeding was found to have umbilical endometriosis. She had no history of pelvic or abdominal surgery. There was no past history of endometriosis or endometriosis-associated symptoms. An omphalectomy was performed after explorative laparoscopy to carefully inspect the abdominopelvic cavity and assess any coexisting pelvic endometriotic lesions. Histological examination confirmed the diagnosis of umbilical endometriosis. Conclusion …

Adultendometriosismedicine.medical_specialtyUmbilicus (mollusc)primary umbilical endometriosisUmbilicuEndometriosislaparoscopyumbilical endometriomalcsh:Gynecology and obstetricsPathogenesisRare DiseasesObstetrics and GynaecologyMedicineHumansEndometriosiLaparoscopylcsh:RG1-991Histological examinationAbdominopelvic cavitymedicine.diagnostic_testbusiness.industryEndometriosis; Laparoscopy; Primary umbilical endometriosis; Umbilical endometrioma; Umbilicus; Obstetrics and GynecologyObstetrics and GynecologyPrimary umbilical endometriosimedicine.diseaseSurgeryumbilicusFemaleUmbilical bleedingbusinessAbdominal surgeryTaiwanese Journal of Obstetrics and Gynecology
researchProduct

Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study.

1993

Objective To evaluate leuprolide acetate (LA) depot (Enantone Depot, Takeda, Italy) when administered preoperatively in hysteroscopic surgery. Design Prospective, comparative study. Setting University Clinic of Obstetrics and Gynecology. Patients One hundred ninety-three patients (114 pretreated with LA depot and 79 controls) who underwent hysteroscopic surgery for uterine septa (group A), submucous fibroids (group B), and abnormal uterine bleeding (group C). Results In groups B and C there was a significant reduction in the operating time, bleeding during the operation, and the amount of distention medium required after LA depot administration, but no significant differences in surgical fe…

Adultmedicine.medical_specialtyDepotHysteroscopyHysteroscopic surgeryEndometriumObstetrics and gynaecologymedicineOperating timeHumansProspective StudiesProspective cohort studyPreoperative treatmentGynecologymedicine.diagnostic_testbusiness.industryUterusUterine bleedingObstetrics and GynecologyGeneral MedicineEndoscopySurgeryClinical trialReproductive MedicineHysteroscopyDelayed-Action PreparationsUterine NeoplasmsMyometriumFemaleUterine HemorrhageLeuprolidebusinessAfter treatmentFertility and sterility
researchProduct

Food Hypersensitivity as a Cause of Rectal Bleeding in Adults

2008

Background & Aims Rectal bleeding and lymphonodular hyperplasia (LNH) in children can be caused by food hypersensitivity (FH). Our aim was to verify whether similar clinical and endoscopy presentations in adults can be due to FH. Methods Consecutive adult patients with rectal bleeding were enrolled. All underwent routine assays, colonoscopy, and histology study. Results Ten of 64 (15%) patients showed LNH as the unique sign at colonoscopy. An oligoantigenic diet resolved the rectal bleeding in 9 patients, and the reintroduction of several foods caused symptom reappearance. Double-blind placebo-controlled challenges with cow's milk and wheat protein confirmed the FH; symptoms reappeared 1–96…

Adultmedicine.medical_specialtyFood hypersensitivitySettore MED/09 - Medicina InternaColonoscopyHemorrhageRecurrent rectal bleedingIleumWheat HypersensitivityFood hypersensitivity; rectal bleeding; adultsGastroenterologyPlacebosDouble-Blind MethodRecurrenceInternal medicineadultsmedicineHumansIntestinal MucosaChildrectal bleedingAgedLamina propriaHyperplasiaHepatologymedicine.diagnostic_testHistocytochemistrybusiness.industryGastroenterologyfood and beveragesHistologyColonoscopyImmunoglobulin EMiddle AgedHyperplasiamedicine.diseaseFood hypersensitivityEndoscopyRectal Diseasesmedicine.anatomical_structureLymph NodesMilk HypersensitivitybusinessClinical Gastroenterology and Hepatology
researchProduct

A randomized comparison of endometrial laser intrauterine thermotherapy and hysteroscopic endometrial resection.

2003

Objective To investigate the difference of long-term amenorrhea rate in patients with menorrhagia treated by endometrial laser intrauterine thermal therapy (ELITT), a new nonhysteroscopic endometrial ablation procedure, versus transcervical hysteroscopic endometrial resection (TCRE). Design Randomized clinical study. Healthy volunteers in an academic research environment. Setting Academic teaching hospital. Patient(s) Premenopausal women with abnormal uterine bleeding. Intervention(s) Fifty-eight patients were treated with the ELITT procedure and 58 patients with TCRE; both groups were treated with GnRH agonists before the procedure. Main outcome measure(s) Bleeding status and patient satis…

Adultmedicine.medical_specialtyIntraoperative ComplicationRandomizationDysfunctional uterine bleedingHysteroscopyEndometriumEndometrial resection laser endometrial ablation amenorrhea dysfunctional uterine bleedinglaw.inventionEndometriumPatient satisfactionRandomized controlled trialDysmenorrhealawmedicineHumansmedicine.diagnostic_testbusiness.industryObstetrics and GynecologyHyperthermia InducedMiddle AgedSettore MED/40 - Ginecologia E OstetriciaSurgeryParitymedicine.anatomical_structureReproductive MedicineHysteroscopyAmenorrheaFemaleUterine Hemorrhagemedicine.symptombusinessFertility and sterility
researchProduct

Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.

2006

Hemorrhagic shock developed in a 29-year-old nullipara without coagulopathy after emergency caesarean section. Treatment with uterotonic drugs, prostaglandins, and conservative procedures with transfusion of packed red cells and fresh-frozen plasma failed to control the diffuse vaginal and uterine bleeding. Finally an intravenous bolus injection of 90 μg/kg recombinant activated factor VII (rFVIIa, NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark), was given and showed success within 20 minutes after administration, without any side effects.

Adultmedicine.medical_specialtyPacked Red CellsCritical IllnessUterotonicFactor VIIa030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicinelawPregnancyActivated factor VIImedicineCoagulopathyHumans030212 general & internal medicinepostpartum bleedingbusiness.industryCesarean SectionPostpartum HemorrhageUterine bleedingHematologyGeneral MedicineFactor VIImedicine.diseaseRecombinant ProteinsSurgeryTreatment OutcomeAnesthesiaHemorrhagic shockRecombinant DNAFemalebusinessClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Ulipristal acetate versus leuprolide acetate for uterine fibroids

2012

A b s t r ac t Background The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear. Methods In this double-blind noninferiority trial, we randomly assigned 307 patients with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy with oral ulipristal acetate (at a dose of either 5 mg or 10 mg) or once-monthly intramuscular injections of leuprolide acetate (at a dose of 3.75 mg). The primary outcome was the proportion of patients with controlled bleeding at week 13, with a prespecified noninferiority margin of −20%. Results Uterine bleed…

Adultmedicine.medical_specialtyUterine fibroidsIntention to Treat AnalysiUrologyAdministration OralEndometriumInjections Intramuscularlaw.inventionchemistry.chemical_compoundYoung AdultEndometriumPrimary outcomeRandomized controlled trialDouble-Blind MethodlawUlipristal acetateSelective progesterone receptor modulatormedicineUterine NeoplasmUlipristalMenorrhagiaGynecologyIntention-to-treat analysisLeiomyomabusiness.industryObstetrics and GynecologyUterine bleedingUterine fibroids uterine leiomyomas uterine bleeding ulipristal acetate leuprolide acetate medical therapyGeneral MedicineNorpregnadieneMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E Ostetriciamedicine.anatomical_structurechemistryAmenorrheaFemalemedicine.symptomLeuprolidebusinessHuman
researchProduct

"GONE WITH THE WIND": The Transitory Effects of COVID-19 on the Gynecological System

2023

The coronavirus disease no longer seems to represent an insurmountable global problem. This is thanks to the advent of coronavirus vaccines, which have alleviated the most serious symptoms associated with this disease. On the other hand, there are still many extrapulmonary symptoms of COVID-19, and among these also those of a gynecological nature. At the moment, there are several questions in this field, one above all concerns the causal link between COVID-19, vaccines and gynecological alterations. Furthermore, another important aspect is represented by the clinical impact of post-COVID-19 gynecological alterations on the female population which, to date, would seem to be mainly due to the…

Anomalous uterine bleedingSARS-CoV-2Vaccine.Medicine (miscellaneous)COVID-19Gynecological and obstetric effectSettore MED/40 - Ginecologia E Ostetricia
researchProduct